Name	Platform	Indication	Status	Collaboration
TRU-015	SMIP	Rheumatoid arthritis	Phase 2b	Wyeth
SBI-087	SMIP	Rheumatoid arthritis	Phase 1	Wyeth
SBI-087	SMIP	Systemic lupus erythematosus	Phase 1	Wyeth
TRU-016	SMIP	Chronic lymphocytic leukemia	Phase 1/2	Trubion Proprietary Technology
TRU-016	SMIP	Non-Hodgkin lymphoma	Pre-clinical	Trubion Proprietary Technology
TRU-016	SMIP	Autoimmune disease and inflammation	Pre-clinical	Trubion Proprietary Technology
